Content provided by the Catalog of Federal Domestic Assistance
93.220 Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds
NATIONAL INSTITUTES OF HEALTH, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Health Service Act, Title IV, Subtitle D, Part G, Section 1631, Public Law 103-43, 107 Stat. 185, 42 U.S.C. 288-5, Public Law 105-392.
To recruit and retain health professionals from disadvantaged backgrounds to conduct clinical research at the National Institutes of Health (NIH) by providing for the repayment of educational loans for participants with substantial amounts of educational debt relative to income, who agree by written contract to engage in clinical research as employees of the NIH for a minimum two-year period.
TYPES OF ASSISTANCE:
USES AND USE RESTRICTIONS:
To provide repayment of extant educational loans incurred by health professionals engaged, as employees of the NIH, in clinical research. Recipients must agree by written contract to engage in such research, initially, for a minimum of 2 years; individuals who have conflicting service obligations may not participate in this program until those obligations are satisfied or have been deferred during the period of program service. One-year continuation contracts are available, dependent upon the level of debt and continued involvement in clinical research. Maximum program benefit is $35,000 per year in loan repayments and $13,650 per year in Federal tax reimbursements. Recipients must have qualified educational debt in excess of 20 percent of their annual salary, which is referred to as their "debt threshold." An amount equal to half of this "debt threshold" will not be repaid by NIH and must be paid by the Program participants.
Applicant Eligibility: Eligible applicants must: (1) Be a citizen, national, or permanent resident of the United States; (2) possess a M.D., Ph.D., D.O., D.D.S., D.M.D., D.V.M., D.P.M., A.D.N., B.S.N., or equivalent degree; (3) come from a disadvantaged background as determined by the Secretary of Health and Human Services; (4) have qualified educational debt, which results from governmental or commercial loans obtained to support their undergraduate and/or graduate education, in excess of 20 percent of their annual NIH salary on the program eligibility date; (5) be appointed under any temporary or permanent employment mechanism, so long as their employment has the potential to last a minimum of 2 years; (6) are not eligible to participate in the CR-LRP if they have an existing service obligation to Federal, State, or other entities, until such obligation is discharged or unless it is deferred during the period of program service; (7) submit an application to participate in the CR-LRP; and (8) sign and submit to the Secretary of Health and Human Services, at the time of agreeing to accept repayment of educational loans, a contract agreeing to engage in clinical research as an employee of the NIH for a minimum of 2 years.
Pre-application Coordination: None. This program is excluded from coverage under E.O. 12372.
Formula and Matching Requirements: This program has no statutory formula or matching requirements.
POST ASSISTANCE REQUIREMENTS:
Reports: Program participants must be certified periodically to have satisfactorily performed the duties of their positions.
Account Identification: 75-0846-0-1-552.
Twenty contracts were awarded in fiscal year 2001. It is anticipated that 24 awards will be made in fiscal year 2002, and 24 awards are anticipated in fiscal year 2003.
REGULATIONS, GUIDELINES, AND LITERATURE:
Pertinent information is contained in Public Law 103-43, Section 1631; Section 487E of Public Health Service Act (42 U.S.C. 288-5); Public Law 105-392; Federal Register, Volume 59, No. 201, October 19, 1994; 42 CFR Part 68a Federal Register, Volume 63, No. 210, October 30, 1998.
Regional or Local Office: Not applicable.
EXAMPLES OF FUNDED PROJECTS:
Clinical and basic research to evaluate the use of a PET imaging agent, Tc-94m sestamibi, which will allow greater resolution and quantitation and thereby make direct quantitative comparisons of tumor uptake before and after treatment with antagonists possible. Clinical and basic research designed to develop better methods for detection, prevention and therapy for patients with kidney cancer. Research on the molecular genetics and protein chemistry of tumor suppressor genes and in particular, the VHL gene; and studies into the treatment of adult solid tumors, and laboratory research projects in tumor immunology and morphology.
CRITERIA FOR SELECTING PROPOSALS:
Applicants are approved for participation in the NIH Clinical Research Loan Repayment Program after the LRC determines that the applicant will conduct qualified clinical research and qualifies as being from a disadvantaged background. LRC approval, in part, is based upon the scientific merit of the research and the credentials of the applicant as they relate to performing qualified clinical research.